Showing 11-20 of 44 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Development of an injectable immunomodulatory niche technology for induction of immune tolerance to islet cell transplants | Stanford University | Eric Appel | Cures | 01-January-2025 to 31-December-2026 | $600.000,00 |
| Exploration of Age-Related Pancreatic Beta Cell Diversity in T1D Using Spatial Transcriptomics | Beckman Research Institute of the City of Hope | Farooq Syed | Cures | 01-October-2024 to 31-January-2026 | $199.999,92 |
| Northern California Breakthrough T1D Center of Excellence | The Regents of the University of California, San Francisco | Qizhi Tang | Cures | 01-October-2024 to 30-September-2028 | $6.000.000,00 |
| Generation of vascularized, transplantable islets from human iPSC-derived beta and isogenic vasculogenic cells | The Regents of the University of California, San Francisco | Julie Sneddon | Cures | 01-July-2024 to 30-June-2026 | $599.999,99 |
| Gaining insight into type 1 diabetes pathogenesis through STAT gain of function | The Regents of the University of California, San Francisco | Martin Thelin | Cures | 01-March-2024 to 28-February-2025 | $110.000,00 |
| Building the Evidence to Address Disparities in Young children with Type 1 Diabetes: BEADY-T1D | Stanford University | Ananta Addala | Improving Lives | 01-February-2025 to 31-January-2029 | $943.983,20 |
| Allogeneic hypoimmunogenic Pancreatic Islets for Treatment of Diabetes in the Intra-Muscular Site | The Regents of the University of California, San Francisco | Tobias Deuse | Cures | 01-August-2024 to 31-July-2026 | $799.998,40 |
| Endothelial cells for islet replacement in diabetes | Stanford University | Martin Neukam | Cures | 01-April-2024 to 31-March-2027 | $251.600,00 |
| Local delivery of immunomodulators to enable systemic immunosuppression-free efficient islet transplantation | The Regents of the University of California, San Francisco | Bhushan Kharbikar | Cures | 01-March-2024 to 28-February-2027 | $285.000,00 |
| Identifying regulators of primary human beta cell survival and proliferation | The Regents of the University of California, San Francisco | Rebecca Lee | Cures | 01-March-2024 to 28-February-2027 | $235.025,00 |